As of November 7, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Alger Russell Innovation ETF. The largest reported stake is Alger Associates, Inc. 13-3017981's, at 24.9%. 11 filings are on record since August 14, 2025 (Schedule 13G, November 6, 2026).
Sell to companies like Alger Russell Innovation ETF? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Alger Associates, Inc. 13-3017981 · Sole voting: 99,482 · Shared voting: 0 · Sole dispositive: 99,482 · Shared dispositive: 0 · SCHEDULE 13G, 2026-11-06
- · Holder: Alger Associates, Inc. · Percent: 2.5% · SCHEDULE 13G/A
- · Holder: Alger Associates, Inc. · Percent: 8.3% · SCHEDULE 13G/A
- · Holder: Alger Associates, Inc. · Percent: 10.8% · SCHEDULE 13G/A
- · Holder: Alger Associates, Inc. · Percent: 0.1% · SCHEDULE 13G/A
Alger Russell Innovation ETF has 11 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of beneficial interest. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Alger Associates, Inc. 13-3017981 | 24.9% | 99,482 | SCHEDULE 13G, 2026-11-06 | 2026-10-31 |
Holding shares or following this stake? See who's behind Alger Russell Innovation ETF and the warning signs.
Free to see. No signup.
Keep reading
More on Alger Russell Innovation ETF and the records around it.
Companies that share a holder
- Alger Associates, Inc. also filed stake reports on 2 other companies: Forte Biosciences, Inc. (Aug 2026), Cryoport, Inc. (Aug 2025)
Watch Alger Russell Innovation ETF
Get an email when Alger Russell Innovation ETF files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Alger Russell Innovation ETF?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Alger Russell Innovation ETF: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alger Russell Innovation ETF covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Alger Associates, Inc. 13-3017981 | 99,482 | 0 | 99,482 | 0 | SCHEDULE 13G, 2026-11-06 |
The latest filing identifies Alger Russell Innovation ETF by CUSIP 015564602 and gives its principal executive office as 100 Pearl Street, 27th Floor, New York, NY 10004 (SCHEDULE 13G, 2026-11-06).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Alger Associates, Inc. | 9.4% | SCHEDULE 13G |
| 2025-08-14 | Alger Associates, Inc. | 34.7% | SCHEDULE 13G/A |
| 2025-08-14 | Alger Associates, Inc. | 5.5% | SCHEDULE 13G/A |
| 2025-10-07 | Alger Associates, Inc. | 14.6% | SCHEDULE 13G/A |
| 2025-10-07 | Alger Associates, Inc. | 0% | SCHEDULE 13G/A |
| 2025-11-14 | Alger Associates, Inc. | 5.2% | SCHEDULE 13G/A |
| 2025-12-05 | Alger Associates, Inc. | 0.1% | SCHEDULE 13G/A |
| 2026-05-15 | Alger Associates, Inc. | 10.8% | SCHEDULE 13G/A |
| 2026-08-14 | Alger Associates, Inc. | 8.3% | SCHEDULE 13G/A |
| 2026-09-08 | Alger Associates, Inc. | 2.5% | SCHEDULE 13G/A |
| 2026-11-06 | Alger Associates, Inc. 13-3017981 | 24.9% | SCHEDULE 13G |
Questions about who owns Alger Russell Innovation ETF
Who owns Alger Russell Innovation ETF?
On this page, one holder's latest ownership filing reports 5% or more of Alger Russell Innovation ETF: Alger Associates, Inc. 13-3017981 (24.9%, Schedule 13G, filed 2026-11-06).
When did Alger Associates, Inc. 13-3017981 buy into Alger Russell Innovation ETF?
The filings give report dates, not purchase dates. The earliest filing from Alger Associates, Inc. 13-3017981 on this page is the Schedule 13G, filed 2026-11-06, reporting 24.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Alger Russell Innovation ETF. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.